The Use of Herbal Products/Dietary Supplements and Affecting Factors in Patients Applying to a Pediatric Neurology Outpatient Clinic: A Descriptive Questionnaire Study

Abstract views: 187 / PDF downloads: 63




epilepsy, herbal products, dietary supplements, herb-drug interaction, pediatric neurology


Objectives: The use of herbal products/dietary supplements (HP/DS) in the pediatric population is increasing day by day. The interaction of HP/DSs with drugs with a narrow therapeutic index such as phenytoin, phenobarbital, and valproic acid, may cause problems in treatment. In this respect, it is very important to determine the use of HP/DS in children with neurological diseases and/or complaints. In this study, it was aimed to determine the use of HP/DS and the factors affecting the use of these products in individuals with a neurological complaint and/or disease who applied to the pediatric neurology outpatient clinic.

Methods: Parents were questioned face-to-face as part of the descriptive questionnaire research. 174 questionnaires with appropriate data quality were included in the study. The statistical software tool SPSS 23.0 was used to analyze the data.

Results: 44.6% of the parents stated that they gave HP/DS to their children. The findings of the analysis showed that kids whose parents use HP/DS are more likely to utilize these items themselves (p<0.001). The most commonly used products are linden (70.1%), bee products (26.0%), carob (18.2%), chamomile (13.0%), and lemon (13.0%).  It has been determined that the reasons for parents to have their children use HP/DS are to strengthen the immune system (51.9%), improve general health status (40.3%), and supplement normal nutrition (27.3%), respectively.

Conclusions: This study revealed a high frequency of HP/DS use in children with pediatric neurological diseases/complaints in Türkiye. The frequency of HP/DS use was higher in children whose parents tended to consume HP/DS. Considering the high use of these products, healthcare professionals need to inform parents to prevent adverse effects caused by HP/DS.


Metrics Loading ...


Chikezie PC, Ojiako OA (2015) Herbal Medicine: Yesterday, today and tomorrow. Altern Integr Med 4:3.

World Health Organization & WHO Expert Committee on Specifications for Pharmaceutical Preparations (‎2018)‎ Fifty-second report of the WHO Expert Committee on specifications for pharmaceutical preparations. Available from Accessed 1 March 2022

Disli M, Yesilada E (2019) Herbal medicinal products in Turkey (Standardization, production and adulteration of herbal products in Turkey). J Biotechnol and Strategic Health Res 3(Special Issue):13-21.

Türkiye Cumhuriyeti Tarım ve Orman Bakanlığı (2013) Türk Gıda Kodeksi Takviye Edici Gıdalar Tebliği. Available from Accessed 1 March 2022

Wegener T (2013) Herbal medicinal products in the pediatric population-status quo and perspectives. Wien Med Wochenschr 163(3-4):46-51.

Zhang Y, Fein EB, Fein SB (2011) Feeding of dietary botanical supplements and teas to infants in the United States. Pediatrics 127(6):1060-1066.

Bulut S, Karakas NM, Deliorman Orhan D (2021) Evaluation of plant and herbal product usage habits in pediatric patients. Health and Society 31(2):172-180.

Zhu Z, Mittal R, Walser SA, Lehman E, Kumar A, Paudel S, Mainali G (2022) Complementary and alternative medicine (CAM) use in children with epilepsy. J Child Neurol 37(5):334-339.

Oskoui M, Ng P, Zaman M, Buckley D, Kirton A, van Rensburg E, Wood E, Shevell M, Majnemer A (2021) Complementary and alternative therapy use in children with cerebral palsy. Can J Neurol Sci 48(3):408-414.

Sinha D, Efron D (2005) Complementary and alternative medicine use in children with attention deficit hyperactivity disorder. J Paediatr Child Health 41(1-2):23-26.

Soo I, Mah JK, Barlow K, Hamiwka L, Wirrell E (2005) Use of complementary and alternative medical therapies in pediatric neurology clinic. Can J Neurol Sci 32(4):524-528.

Chen C, Chong YJ, Hie SL, Sultana R, Lee SHD, Chan WSD, Chan SY, Cheong HH (2016) Complementary and alternative medicines use among pediatric patients with epilepsy in a multiethnic community. Epilepsy Behav 60:68-74.

Lee JY, Choi WS, Eun SH, Eun BL, Hong YS, Lee JW (2008) Use of herbal medicine in epileptic children. Clin Exp Pediatr 51(4):415-419.

OpenEpi. Available from Accessed 05 April 2021

Pars H, Suluhan D, Ercan E (2020) Use of traditional complementary treatment by the mothers with asthmatic children and the effect of their knowledge about the disease on the control of asthma: a single-center experience. J Tradit Complem Med 3(1):1-10.

Galicia-Connolly E, Adams D, Bateman J, Dagenais S, Clifford T, Baydala L, King WJ, Vohra S (2014) CAM use in pediatric neurology: an exploration of concurrent use with conventional medicine. PLoS One 9(4):e94078.

Al-Rumayyan A, Alqarni H, Almanna BS, Althonayan N, Alhalafi M, Alomary N (2020) Utilization of complementary medicine by pediatric neurology patients and their families in Saudi Arabia. Cureus 12(5):e7960.

Carman KB, Lacinel-Gurlevik S, Kaplan E, Dinleyici M, Yarar C, Arslantas D (2018) The evaluation of use of complementary and alternative medicine practices in the treatment of children with chronic neurological disease. Haydarpasa Numune Med J 58(3):117-121.

Doering JH, Reuner G, Kadish NE, Pietz J, Schubert-Bast S (2013) Pattern and predictors of complementary and alternative medicine (CAM) use among pediatric patients with epilepsy. Epilepsy Behav 29(1):41-46.

Jeong MJ, Lee HY, Lim JH, Yun YJ (2016) Current utilization and influencing factors of complementary and alternative medicine among children with neuropsychiatric disease: a cross-sectional survey in Korea. BMC Complement Altern Med 16:91.

Hartmann N, Neininger MP, Bernhard MK, Syrbe S, Nickel P, Merkenschlager A, Kiess W, Bertsche T, Bertsche A (2016) Use of complementary and alternative medicine (CAM) by parents in their children and adolescents with epilepsy - Prevelance, predictors and parents' assessment. Eur J Paediatr Neurol 20(1):11-19.

Naja F, Alameddine M, Abboud M, Bustami D, Al Halaby R (2011) Complementary and alternative medicine use among pediatric patients with leukemia: the case of Lebanon. Integr Cancer Ther 10(1):38-46.

Yeon GM, Nam SO (2016) The use of complementary and alternative medicine in children with common neurologic diseases. Korean J Pediatr 59(8):313-318.

Tuncel T, Sen V, Kelekci S, Karabel M, Sahin C, Uluca U, Karabel D, Haspolat YK (2014) Use of complementary and alternative medicine in children who have no chronic disease. Turk Arch Pediatr 49(2):148-153.

Du Y, Wolf IK, Zhuang W, Bodemann S, Knöss W, Knopf H (2014) Use of herbal medicinal products among children and adolescents in Germany. BMC Complement Altern Med 14:218.

Hanson E, Kalish LA, Bunce E, Curtis C, McDaniel S, Ware J, Petry J (2007) Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder. J Autism Dev Disord 37(4):628-636.

Davis MP, Darden PM (2003) Use of complementary and alternative medicine by children in the United States. Arch Pediatr Adolesc Med 157(4):393-396.

Birdee GS, Phillips RS, Davis RB, Gardiner P (2010) Factors associated with pediatric use of complementary and alternative medicine. Pediatrics 125(2):249-256.

Liao HH, Yen HR, Muo CH, Lee YC, Wu MY, Chou LW, Sun MF, Chang TT (2017) Complementary traditional Chinese medicine use in children with cerebral palsy: a nationwide retrospective cohort study in Taiwan. BMC Complement Altern Med 17(1):155.

Dulger G (2012) Herbal drugs and drug interactions. Marmara Pharm J 16:9-22.

Garg SK, Kumar N, Bhargava VK, Prabhakar SK (1998) Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clin Pharmacol Ther 64(3):286-288.

Gurley B, Hubbard MA, Williams DK, Thaden J, Tong Y, Gentry WB, Breen P, Carrier DJ, Cheboyina S (2006) Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin. J Clin Pharmacol 46(2):201-213.

Lilja JJ, Backman JT, Neuvonen PJ (2007) Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam--probes of CYP2C9, CYP1A2, and CYP3A4. Clin Pharmacol Ther 81(6):833-839.

Wongnawa M, Soontaro P, Riditid W, Wongpoowarak P, Ruengkittisakul S (2012) Andrographis paniculata (Burm.f.) Nees on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers. Songklanakarin J Sci Technol 34(5):533-539.

Johannessen Landmark C, Patsalos PN (2008) Interactions between antiepileptic drugs and herbal medicines. Bol Latinoam Caribe Plant Med Aromaticas 7(2):109-118.

Kupiec T, Raj V (2005) Fatal seizures due to potential herb-drug interactions with Ginkgo biloba. J Anal Toxicol 29(7):755-758.

Mochizuki K, Hamano Y, Miyama H, Arakawa K, Kobayashi T, Imamura H (2015) Successful treatment of a case with concurrent ingestion of carbamazepine overdose and grapefruit juice. Acute Med Surg 3(1):36-38.

Lantz MS, Buchalter E, Giambanco V (1999) St. John’s wort and antidepressant drug interactions in the elderly. J Geriatr Psychiatry Neurol 12:7-10.

Williamson EM, Driver SM, Baxter K (2009) Stockley’s herbal medicines interactions: A guide to the interactions of herbal medicines, dietary supplements and nutraceuticals with conventional medicines, 2nd edn. pp:360-380, Pharmaceutical Press, London.




How to Cite

Gökkaya, İçim, Subaş, T., Renda, G., Şahin, S., Özgen, U., Yıldız, N., & Cansu, A. (2023). The Use of Herbal Products/Dietary Supplements and Affecting Factors in Patients Applying to a Pediatric Neurology Outpatient Clinic: A Descriptive Questionnaire Study. European Journal of Therapeutics, 29(4), 873–882.



Original Articles